Preclinical characterization of ARX517, a next-generation anti-PSMA antibody drug conjugate for the treatment of metastatic castration-resistant prostate cancer

被引：2
|
作者：
Skidmore, Lillian
Mills, David
Kim, Ji Young
Shastri, Prathap
Knudsen, Nick A.
Steen, Jeff
Nelson, Jay
Buechler, Ying
Tian, Feng
Zhang, Shawn
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3997
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC).
    Petrylak, Daniel Peter
    Smith, David C.
    Appleman, Leonard Joseph
    Fleming, Mark T.
    Hussain, Arif
    Dreicer, Robert
    Sartor, A. Oliver
    Shore, Neal D.
    Vogelzang, Nicholas J.
    Youssoufian, Hagop
    Olson, William C.
    Stambler, Nancy
    Huang, Kathleen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [22] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane.
    Mega, Anthony E.
    Petrylak, Daniel Peter
    Kantoff, Philip
    Stephenson, Joe
    Vogelzang, Nicholas J.
    Dreicer, Robert
    Shore, Neal D.
    Stambler, Nancy
    Carpenito, Jennifer
    D'Ambrosio, Paul
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival
    Demirci, E.
    Akyel, R.
    Sahin, O.
    Ocak, M.
    Aygun, A.
    Pehlivanoglu, H.
    Karayel, E.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S202 - S203
  • [24] Lu-177 PSMA Radioligand Therapy as Salvage Treatment in Metastatic Castration-Resistant Prostate Cancer
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Langbein, T.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S287 - S288
  • [25] Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer
    Wang, Fangming
    Wu, Liyuan
    Yin, Le
    Shi, Hui
    Gu, Yuchun
    Xing, Nianzeng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (06):
  • [26] Radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (CRPC).
    Akhtar, N. H.
    Nanus, D. M.
    Vallabhajosula, S.
    Osborne, J.
    Beltran, H.
    Tyrell, L.
    Nadeau, K.
    Saran, A.
    Mileo, G.
    Goldsmith, S. J.
    Bander, N. H.
    Tagawa, S. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Hernandez-Hoyos, Gabriela
    Sewell, Toddy
    Bader, Robert
    Bannink, Jeannette
    Chenault, Ruth A.
    Daugherty, Mollie
    Dasovich, Maria
    Fang, Hang
    Gottschalk, Rebecca
    Kumer, John
    Miller, Robert E.
    Ravikumar, Padma
    Wiens, Jennifer
    Algate, Paul A.
    Bienvenue, David
    McMahan, Catherine J.
    Natarajan, Sateesh K.
    Gross, Jane A.
    Blankenship, John W.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) : 2155 - 2165
  • [28] Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents
    Pezaro, Carmel J.
    Omlin, Aurelius G.
    Altavilla, Amelia
    Lorente, David
    Ferraldeschi, Roberta
    Bianchini, Diletta
    Dearnaley, David
    Parker, Christopher
    de Bono, Johann S.
    Attard, Gerhardt
    EUROPEAN UROLOGY, 2014, 66 (03) : 459 - 465
  • [29] APEX-01: First-in-human phase I/II study of ARX517 an antiprostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC)
    Shen, J.
    Pachynski, R.
    Nordquist, L. T.
    Adra, N.
    Bilen, M. A.
    Aggarwal, R.
    Reichert, Z.
    Schweizer, M.
    Iravani, A.
    Aung, S.
    Hessel, C.
    Tagawa, S. T.
    ANNALS OF ONCOLOGY, 2023, 34 : S974 - S975
  • [30] Novel 212Pb-PSMA Targeted Alpha Therapy for the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Kryza, T.
    Liu, F.
    Li, K. C.
    Francis, P.
    Kuan, K.
    Tieu, W.
    Akhter, D.
    Fletcher, N.
    Taylor, S.
    Karmann, A.
    Rose, S.
    Puttick, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S254 - S255
12345